(19)
(11) EP 1 843 769 A1

(12)

(43) Date of publication:
17.10.2007 Bulletin 2007/42

(21) Application number: 05826405.2

(22) Date of filing: 22.12.2005
(51) International Patent Classification (IPC): 
A61K 31/4985(2006.01)
A61P 1/04(2006.01)
A61P 9/00(2006.01)
A61P 9/12(2006.01)
A61P 25/02(2006.01)
A61P 25/14(2006.01)
A61P 25/18(2006.01)
A61P 25/22(2006.01)
A61P 1/00(2006.01)
A61P 3/04(2006.01)
A61P 9/10(2006.01)
A61P 25/00(2006.01)
A61P 25/06(2006.01)
A61P 25/16(2006.01)
A61P 25/20(2006.01)
(86) International application number:
PCT/IB2005/003979
(87) International publication number:
WO 2006/072832 (13.07.2006 Gazette 2006/28)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 07.01.2005 US 642083 P

(71) Applicant: Pfizer Products Incorporated
Groton, CT 06340 (US)

(72) Inventors:
  • JOHNSON, Barbara Alice
    Groton, CT 06340 (US)
  • ZIEGLER, Carl, Bernard, Jr.
    Groton, CT 06340 (US)

(74) Representative: Hodge, Emma Jane et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) FAST-DISINTEGRATING DOSAGE FORMS OF 5,8,14-TRIAZATETRACYCLO[10.3.1.02,11.04,9]-HEXADECA-2(11),3,5,7,9-PENTAENE